Molecular targets in the treatment of anxiety (Q35001313)

5 August 2017

1 reference

title

Molecular targets in the treatment of anxiety (English)

1 reference

5 August 2017

Justine M Kent

1

1 reference

5 August 2017

Sanjay J Mathew

series ordinal

2

1 reference

5 August 2017

Jack M Gorman

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

published in

Biological Psychiatry

1 reference

5 August 2017

volume

52

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

1008-1030

1 reference

Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Blunted growth hormone response to clonidine in patients with generalized anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Corticotropin-releasing factor receptors: distribution and regulation in brain, pituitary, and peripheral tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Effects of chronic stress on anterior pituitary and brain corticotropin-releasing factor receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Prolactin response to dl-fenfluramine in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

5-HT and antidepressants: new views from microdialysis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonin, anxiety, and stress hormones. Focus on 5-HT receptor subtypes, species and gender differences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Current treatments of the anxiety disorders in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Fluoxetine: a review of receptor and functional effects and their clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Antidepressant effects of ketamine in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Elevated plasma levels of neuropeptide Y in patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

α2-Adrenergic receptor sensitivity in panic disorder: I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Beta-adrenergic activation and memory for emotional events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Central olfactory connections in the macaque monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The effect of raising or lowering tryptophan levels on aggression in vervet monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonin function in anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

An autoradiographic study of serotonergic receptors in a murine genetic model of anxiety-related behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

A Controlled Comparative Trial of Mianserin and Diazepam in the Treatment of Anxiety States in Psychiatric Out-Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Plasma cortisol concentrations preceding lactate-induced panic. Psychological, biochemical, and physiological correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The nagging question of the function of N-acetylaspartylglutamate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

N-methyl-D-aspartate (NMDA)-mediated corticotropin-releasing factor (CRF) release in cultured rat amygdala neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The CRF peptide family and their receptors: yet more partners discovered

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The 5-HT3B subunit is a major determinant of serotonin-receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The role of the amygdala in fear and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The amygdala: vigilance and emotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

5-HT1A receptor agonists: recent developments and controversial issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The pharmacology and mechanism of action of riluzole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

A molecular and cellular theory of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Recent developments in anxiety, stress, and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Efficacy of ondansetron in the treatment of generalized anxiety disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Stress and brain noradrenaline: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Production and characterization of a specific 5-HT2 receptor antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Plasma levels of gamma-aminobutyric acid and panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Mirtazapine in major depression with comorbid generalized anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Noradrenergic denervation prevents sensitization of rat forebrain neurons to serotonin by tricyclic antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Excitation of neurons in the nucleus locus coeruleus by substance P and related peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Galanin and NPY, two peptides with multiple putative roles in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Molecular, pharmacological and functional diversity of 5-HT receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The glutamate antagonist riluzole and its effects upon basal and stress-induced activity of the human hypothalamus-pituitary-adrenocortical system in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Update on Substance P (NK-1 receptor) antagonists in clinical trials for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Emotional memory systems in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Emotion: clues from the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Fear and the brain: where have we been, and where are we going?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Psychiatric adverse events during vigabatrin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Molecular and neuronal substrate for the selective attenuation of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Glutamate transporters in neurologic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Neurobiological mechanisms of social anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Glutamate-hypothalamic-pituitary-adrenal axis interactions: implications for mood and anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonin in Panic Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Plasma neuropeptide-Y concentrations in humans exposed to military survival training

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The effect of tryptophan on social interaction in everyday life: a placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

High-affinity platelet [3H]LSD binding is decreased in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Altered central alpha 2-adrenoceptor sensitivity in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Neurotransmitter functions of mammalian tachykinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Treatment of social phobia with gabapentin: a placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Placebo-controlled study of gabapentin treatment of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Allosteric modulation of 5-HT3 receptors: focus on alcohols and anaesthetic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Increased anxiety of mice lacking the serotonin1A receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

5-HT 1B/D receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Pilot study of secondary prevention of posttraumatic stress disorder with propranolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Fear conditioning enhances different temporal components of tone-evoked spike trains in auditory cortex and lateral amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Mirtazapine versus fluoxetine in the treatment of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Tachykinin NK(3)receptor involvement in anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Multiple serotonin receptors: clinical and experimental aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Vigabatrin has an anxiolytic effect in the elevated plus-maze test of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Ondansetron in the treatment of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The relative efficacy of buspirone, imipramine and placebo in panic disorder: A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Effect of the GABA-transaminase inhibitor vigabatrin on exploratory behaviour in socially isolated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Antidepressants for the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Abnormal noradrenergic function in posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The use of a priori knowledge to quantify short echo in vivo1h mr spectra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Plasma neuropeptide Y in anxiety disorders: findings in panic disorder and social phobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Riluzole antagonizes the anxiogenic properties of the beta-carboline FG 7142 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Expression of preprogalanin mRNA following acute and chronic restraint stress in brains of normotensive and hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Role of CRF(1) and CRF(2) receptors in fear and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Fenfluramine provocation of anxiety in patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: a [(11)C]WAY-100635 PET investigation in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

In vivo 1H NMR spectroscopy of the human brain at 7 T.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Stressor predictability and rat brain noradrenaline metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Anxiolytic effects of vigabatrin in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

7 January 2021

Effects of LY354740, a novel glutamatergic metabotropic agonist, on nonhuman primate hypothalamic-pituitary-adrenal axis and noradrenergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

7 January 2021

Evaluation of perospirone (SM-9018), a novel serotonin-2 and dopamine-2 receptor antagonist, and other antipsychotics in the conditioned fear stress-induced freezing behavior model in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

7 January 2021

Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

7 January 2021

Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

7 January 2021

Differential changes in noradrenaline turnover in specific regions of rat brain produced by controllable and uncontrollable shocks

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901672-4

7 January 2021

10.1016/S0006-3223(02)01672-4

Identifiers

DOI

1 reference

5 August 2017

1 reference